These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30376745)

  • 21. Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database.
    Hsieh MH; Chuang PY; Wu CS; Chang CJ; Chung PF; Tang CH
    J Affect Disord; 2017 Aug; 218():327-334. PubMed ID: 28494390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder.
    Yan T; Greene M; Chang E; Houle CR; Tarbox MH; Broder MS
    Clinicoecon Outcomes Res; 2020; 12():81-89. PubMed ID: 32104020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Dashputre AA; Gatwood KS; Gatwood J
    J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics.
    Pilon D; Patel C; Lafeuille MH; Zhdanava M; Lin D; Côté-Sergent A; Rossi C; Lefebvre P; Joshi K
    J Manag Care Spec Pharm; 2021 Jul; 27(7):904-914. PubMed ID: 34185557
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
    Hassan M; Madhavan SS; Kalsekar ID; Makela EH; Rajagopalan K; Islam S; Kavookjian J; Miller LA
    Ann Pharmacother; 2007 Nov; 41(11):1812-8. PubMed ID: 17925501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Earlier Versus Later Augmentation with an Antipsychotic Medication in Patients with Major Depressive Disorder Demonstrating Inadequate Efficacy in Response to Antidepressants: A Retrospective Analysis of US Claims Data.
    Yermilov I; Greene M; Chang E; Hartry A; Yan T; Broder MS
    Adv Ther; 2018 Dec; 35(12):2138-2151. PubMed ID: 30456519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K; Farley JF; Maciejewski ML; Domino ME
    J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population.
    Joshi K; Muser E; Xu Y; Schwab P; Datar M; Suehs B
    J Comp Eff Res; 2018 Aug; 7(8):723-735. PubMed ID: 29722547
    [No Abstract]   [Full Text] [Related]  

  • 29. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization.
    Markowitz M; Karve S; Panish J; Candrilli SD; Alphs L
    BMC Psychiatry; 2013 Oct; 13():246. PubMed ID: 24094241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics.
    Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS
    Curr Med Res Opin; 2018 Jan; 34(1):41-47. PubMed ID: 29057674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
    Niu X; Dennen S; Dembek C; Laubmeier K; Liu Y; Veeranki P; Tocco M; Williams GR
    Curr Ther Res Clin Exp; 2021; 94():100629. PubMed ID: 34306269
    [No Abstract]   [Full Text] [Related]  

  • 34. Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study.
    Kadakia A; Dembek C; Liu Y; Dieyi C; Williams GR
    J Med Econ; 2021; 24(1):1212-1220. PubMed ID: 34647502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US.
    Manjelievskaia J; Amos TB; El Khoury AC; Vlahiotis A; Cole A; Juneau P
    J Med Econ; 2018 Dec; 21(12):1221-1229. PubMed ID: 30238806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
    Offord S; Lin J; Mirski D; Wong B
    Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to oral diabetes medications among users and nonusers of antipsychotic medication.
    Desai PR; Adeyemi AO; Richards KM; Lawson KA
    Psychiatr Serv; 2014 Feb; 65(2):215-20. PubMed ID: 24233254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between non-compliance with psychiatric treatment and non-psychiatric service utilization and costs in patients with schizophrenia and related disorders.
    Joe S; Lee JS
    BMC Psychiatry; 2016 Dec; 16(1):444. PubMed ID: 27955645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.
    Joshi K; Pan X; Wang R; Yang E; Benson C
    Curr Med Res Opin; 2016 Nov; 32(11):1873-1881. PubMed ID: 27479694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.
    Rascati KL; Richards KM; Ott CA; Goddard AW; Stafkey-Mailey D; Alvir J; Sanders KN; Mychaskiw M
    Psychiatr Serv; 2011 Sep; 62(9):1032-40. PubMed ID: 21885581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.